CYCLERION THERAPEUTICS, INC. (KRSA) Net margin 2019–2025
CYCLERION THERAPEUTICS, INC. (KRSA) net profit margin by fiscal year — reported net income divided by reported revenue.
-170.1%FY2025 · since FY2019: -2729.3% → -170.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -170.1% | -17.3 pp |
| FY2024 | -152.8% | — |
| FY2022 | -14841.1% | -13530.9 pp |
| FY2021 | -1310.2% | +2078.4 pp |
| FY2020 | -3388.6% | -659.3 pp |
| FY2019 | -2729.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More KRSA financial trends
KRSA RevenueKRSA Net incomeKRSA Gross profitKRSA Gross marginKRSA Operating incomeKRSA Operating marginKRSA Operating cash flowKRSA Free cash flowKRSA Capital expendituresKRSA Return on equityKRSA Stock buybacksKRSA Dividends paidKRSA Total assetsKRSA Total liabilitiesKRSA Shareholders’ equityKRSA overview →